Orthostatic hypotension
Not recruitingStudy on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy
Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy
- Disease:Orthostatic hypotension
- Substances:AmpreloxetineMidodrine Hydrochloride
Portugal- Participants:18–64 years · 65+ years
- Substances:Ampreloxetine
- Sponsor:Theravance Biopharma Ireland Limited



